España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Meg Flippin
Benzinga Staff Writer
About
Meg is an award-winning journalist writing about personal finance, technology, investing and a host of other topics for several national publications. She has a knack for taking even the most complex topic and breaking it down for the masses.
Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study
Sponsored
How Jupiter Neuroscience's Two-Prong Approach Could Crack The Code On Biotech Success
Sponsored
How TNL Mediagene Is Leveraging Acquisitions And Organic Growth To Become The Largest Media Tech Company In Southeast Asia
Sponsored
Armed With Donation From Trial Participant's Family, Cognition (Nasdaq: CGTX) Initiates Expanded Access Program For Experimental DLB Drug
Sponsored
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Sponsored
Q1 Earnings: Seanergy Beats Topline And Bottomline Analyst Estimates, Both SHIP And Spin-Off USEA Declare Dividends
Sponsored
The Journey Continues: Pasofino Back On Track To Production After Raising $3.6 Million In A Private Placement To Advance Its Dugbe Gold Project
Sponsored
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Sponsored
How This Subprime Auto Lender With 55 Straight Quarters Of Profit Is Standing Out From The Pack
Sponsored
LogicMark's Holistic Approach: Leveraging Artificial Intelligence And SaaS To Protect Aging Loved Ones
Sponsored
Watch Out Canada Goose And Moncler – Perfect Moment May Be The Trending Skiwear Brand To Watch
Sponsored
Pushing The Boundaries Of Innovation: How Sportradar Is Setting New Industry Standards
Sponsored
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
Sponsored
Lottery.com Expands Into Concerts And Niche Live Events With DotCom Ventures Acquisition
Sponsored
Ascent Solar Inks Deal With NOVI As Its Space Business Takes Off
Sponsored
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market
Sponsored
TNL Mediagene Getting Noticed On Wall Street: Benchmark Equity Research Starts Coverage With Speculative Buy, $3.50 Per Share Price Target
Sponsored
Connected Vehicles Are Leaping Into The Driver's Lane, And Iteris' Software And Hardware Stack Is Playing A Role
Sponsored
Indaptus Therapeutics Q1 Update: Company Advances Decoy20 Immunotherapy To Fight Cancer, Maxim Group Analyst Reiterates Buy Rating
Sponsored
Mining For Gold In Africa: Pasofino Gold Shares Progress On Its 400 Million Ounce Gold Project
Sponsored